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Current clinical and epidemiological research provides support for a continuum of 
bipolar psychopathology: a bipolar spectrum that ranges from subthreshold 
characteristics to clinical disorders. The present research examined the predictive validity 
of the Hypomanic Personality Scale (HPS) as a measure of bipolar spectrum 
psychopathology in a nonclinically ascertained sample of young adults at a 3-year follow-
up assessment. Thus far, 100 of the original 145 participants have been re-interviewed for 
bipolar psychopathology, borderline and schizotypal personality disorder symptoms, 
substance use, treatment history, family history, and psychosocial functioning. At the 
original assessment, 15 of the 100 participants met criteria for a bipolar spectrum 
disorder. At the follow-up assessment, an additional 13 had developed bipolar spectrum 
disorders. A total of 26% of participants met criteria for bipolar spectrum disorders at the 
follow-up, including 10% with DSM-IV-TR disorders. The HPS predicted new cases and 
total number of cases of bipolar spectrum disorders, as well as total number of DSM-IV-
TR bipolar disorders at the follow-up assessment. The HPS also predicted current 
hyperthymic temperament or history of hypomania, grandiose traits, impulsivity, 
substance use disorders, global impairment, and borderline and schizotypal traits. The 
majority of these effects were significant after removing participants with DSM-IV-TR 
bipolar disorders from the analyses, suggesting that the results were not driven by a 
subset of participants with clinical disorders. Contrary to hypotheses, impulsivity did not 
 
 
moderate the predictive validity of the HPS.  Overall, these results offer further support 
for the bipolar spectrum construct and the predictive validity of the HPS as a measure of 
bipolar spectrum psychopathology.  
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CHAPTER I 
 
INTRODUCTION 
 
 
Current clinical and epidemiological research provides support for a broad 
spectrum of bipolar psychopathology (e.g., Akiskal et al., 2000; Alloy, Urošević, et al., 
2012; Angst et al., 2003; Paris, 2009; Phelps, Angst, Katzow, & Sadler, 2008; Vieta & 
Phillips, 2007). The bipolar spectrum includes, but extends beyond, the boundaries of the 
Diagnostic and Statistical Manual of Mental Disorders, 4
th
 Edition, Text Revision (DSM-
IV-TR; American Psychiatric Association, 2000). The Hypomanic Personality Scale 
(HPS; Eckblad & Chapman, 1986) offers a promising point of entry for studying the 
bipolar spectrum construct. The present research involved a 3-year follow-up assessment 
of young adults who completed the HPS and a comprehensive cross-sectional assessment 
(see Walsh, Royal, Brown, Barrantes-Vidal, & Kwapil, 2012). Specifically, the present 
research examined the predictive validity of the HPS as a measure of bipolar spectrum 
psychopathology, as well as the moderating role of impulsivity on the relation of the HPS 
with psychopathology and impairment. Additionally, the present study included a 
preliminary examination of the validity of a continuous rating system for measuring 
bipolar spectrum characteristics. 
The Bipolar Spectrum 
Bipolar disorder has been ranked by the World Health Organization (2008) as one 
of the top ten causes of disability worldwide and is associated with premature mortality,
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largely resulting from suicide and accidental death (Calabrese et al., 2003; Osby, Brandt, 
Correia, Ekborn, & Sparen, 2001). The DSM-IV-TR recognizes four bipolar disorders: 
bipolar I disorder, bipolar II disorder, cyclothymic disorder, and bipolar disorder not 
otherwise specified (bipolar NOS). Traditionally, bipolar disorders have been estimated 
to affect approximately 1-2% of the general population (Bauer & Pfennig, 2005; Pini et 
al., 2005). However, recent epidemiological studies suggest that this estimate is 
conservative and discounts the growing evidence for a continuum of bipolar spectrum 
psychopathology (e.g., Angst, 1998; Angst et al., 2003, 2010; Hoertel, Le Strat, Angst, & 
Dubertret, 2013; Merikangas et al., 2007; Zimmermann et al., 2009). Akiskal and 
colleagues (2000) estimated that the bipolar spectrum characterizes approximately 5% of 
the general population. Akiskal (2004) proposed a spectrum of bipolar disorders that 
extends beyond the DSM-IV-TR diagnoses. In addition to bipolar I and II disorders, 
Akiskal proposed bipolar II ½ (major depression superimposed on cyclothymic 
temperament), bipolar III (major depression plus hypomania occurring solely in 
association with antidepressant or other somatic treatment), and bipolar IV (major 
depression superimposed on hyperthymic temperament). Note that other authors have 
suggested six or more variations of bipolar disorder (Akiskal & Pinto, 1999; Klerman, 
1987). Consistent with the categorical nature of the DSM-IV-TR, Akiskal’s conditions 
represent discrete diagnostic categories. Expanding the diagnostic criteria beyond 
categorical boundaries, however, has important implications for understanding the 
etiology, potential developmental trajectories, and treatment of mood disorders. For 
example, examining subthreshold characteristics of bipolar disorder may identify 
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individuals at risk for clinical disorders, promote early interventions and monitoring, and 
increase the likelihood of patients receiving appropriate treatment (Angst & Cassano, 
2005). Furthermore, increased research on these subthreshold characteristics may 
elucidate specific risk and protective factors. Greater attention to subclinical bipolarity in 
clinical practice should also encourage focus on minimizing the severity and frequency of 
episodes, and treating symptoms and impairment, rather than a specific diagnosis. 
Evidence for a Broader Bipolar Spectrum 
Epidemiology. Several large epidemiological studies provided evidence of milder 
bipolar psychopathology that extends beyond the current diagnostic boundaries. Using 
data collected from 4,547 young adults identified as high risk for psychiatric disorders 
from the longitudinal Zurich Cohort Study, Angst (1998) demonstrated high rates of 
subclinical hypomania. Angst classified hypomanic syndromes as follows: hypomania 
lasting at least 4 days and meeting criteria defined in the Diagnostic and Statistical 
Manual, 4
th
 Edition (DSM-IV; American Psychiatric Association, 1994), brief 
hypomania (hypomania syndromes meeting DSM-IV symptomatic criteria but lasting 
only 1-3 days), and isolated hypomanic symptoms that do not meet the requirements of 
the other categories. Angst reported that 6% of the sample met criteria for DSM-IV 
hypomania or mania, 3% experienced brief hypomanias (and half of this group reported 
experiencing brief hypomania at least once per month), and 11% of the sample reported 
experiencing subthreshold hypomanic symptoms.  
 Using the same high risk sample, Angst et al. (2003) examined the validity of 
several bipolar spectrum conditions as follows:  
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 Bipolar I disorder: mania requiring hospitalization plus major depressive episode(s) 
(MDE)  
 Hard bipolar II disorder: > three hypomanic symptoms with consequences plus 
MDE 
 Soft bipolar II disorder: > three hypomanic symptoms plus MDE  
 Hard minor bipolar disorder: > three hypomanic symptoms with consequences plus 
dysthymia, subthreshold depression, or recurrent brief depression (less than 2 weeks 
duration)  
 Soft minor bipolar disorder: > three hypomanic symptoms plus dysthymia, 
subthreshold depression, or recurrent brief depression  
 Pure hypomania: > three hypomanic symptoms with consequences without 
depressive symptoms 
 Hypomanic symptoms: > three hypomanic symptoms without depressive symptoms 
Note that the authors eliminated any duration requirement across all conditions, and 
euphoria, irritability, or overactivity was required for all hypomanic conditions. 
Overactivity was defined as a transient increase in physical or social activity associated 
with increased energy, activity, traveling, talking, being busier, decreased 
“fatiguableness,” and/or decreased need for sleep. Hypomanic symptoms with 
consequences referred to a change in functioning that was observable by others and/or 
causing problems for the participant. Angst et al. (2003) reported that 5% of participants 
met criteria for hard bipolar II disorder and an additional 6% reported symptoms of soft 
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bipolar II disorder. Six percent of participants reported symptoms consistent with soft 
minor bipolar disorder, and 3% of participants met criteria for the harder definition. 
There were higher rates of hypomanic symptoms (9%) in comparison to pure hypomania 
(3%). The authors also compared the hard and soft bipolar groups within bipolar II 
disorder and minor bipolar disorder and reported no between-group differences with 
respect to any external clinical validators, including number of days per year 
experiencing hypomanic or depressive symptoms, age of onset, suicide attempts, 
treatment for depression, anxiety disorders, substance abuse or dependence, conduct 
problems, or criminal offenses. Additionally, the combined group of individuals who met 
criteria for a hard or soft bipolar disorder exceeded individuals with major depressive 
disorder with regard to history of substance abuse or dependence and conduct problems. 
Note that this analysis was not completed with minor bipolar disorders. Taken together, 
Angst et al. (2003) reported a strikingly high prevalence rate of 24% for the bipolar 
spectrum, including individuals with bipolar I disorder and excluding individuals with 
isolated hypomanic symptoms without consequences (although note that this was a high 
risk sample, not an epidemiological sample).  
 In addition to examining the rates of bipolar spectrum conditions, Angst and 
colleagues (2003) also examined the validity of the symptom and duration thresholds 
required for DSM-IV hypomania. The authors found no differences between groups 
reporting a history of 2-3 symptoms, 4-5 symptoms, or 6-7 symptoms with regard to 
clinical variables, including age of onset, history of depression, depression treatment, 
criminal offenses, suicide attempts, and duration of hypomanic or mixed symptoms 
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within a 1-year period. Experiencing 6-7 hypomanic symptoms was, however, associated 
with increased number of days depressed over a 1-year period. Angst et al. (2003) also 
tested the validity of the inclusion of individuals with a history of overactivity in the 
absence of euphoria or irritability. They reported no differences between groups 
exhibiting mood symptoms and overactivity versus overactivity alone. Angst et al. (2003) 
concluded that these results support the addition of overactive behavior as a criterion for 
hypomania. With regard to duration of hypomania, the authors compared participants 
who experienced brief hypomanic episodes (1-3 days) with those meeting DSM-IV 
duration criteria (at least 4 days). As expected, individuals reporting threshold duration 
for hypomania experienced more hypomanic days within a 1-year period; however, 
comparisons on the remainder of the clinical variables were non-significant. The authors 
indicated that their findings were in agreement with the 2-day duration requirement for 
hypomania recommended by an expert group (Akiskal et al., 2000; Cassano, Akiskal, 
Savino, Musetti, & Perugi, 1992; Manning, Haykal, Connor, & Akiskal, 1997) and often 
used in clinical practice (Akiskal et al., 2000; Benazzi, 2001).  
 Merikangas and colleagues (2007) examined the prevalence of subthreshold 
bipolar disorder as part of the US National Comorbidity Replication Study (NCS-R; 
Kessler & Merikangas, 2004). Subthreshold bipolar disorder was defined as any of the 
following: a) at least two episodes of DSM-IV hypomania without major depression, b) 
recurrent subthreshold hypomania plus major depression, or c) recurrent subthreshold 
hypomania without major depression. Note that subthreshold hypomania was defined just 
below the DSM-IV threshold: euphoria or irritability lasting at least 4 days with at least 
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two additional symptoms. Of the 9,282 adults surveyed, 2% met criteria for subthreshold 
bipolar disorder in their lifetime, with 4% of participants qualifying for a subthreshold or 
DSM-IV bipolar disorder. The authors reported that 46% of adults with subthreshold 
bipolar disorder experienced severe role impairment during the previous year associated 
with hypomanic symptoms. 
 Using data from the prospective longitudinal Early Development Stages of  
Psychopathology study in Munich (EDSP; Lieb, Isensee, von Sydow, & Wittchen, 2000; 
Wittchen, Perkonigg, Lachner, & Nelson, 1998), Zimmermann and colleagues (2009) 
examined the incidence of the following disorders in a community sample at a 10-year 
follow-up assessment: 
 Subthreshold bipolar disorder: major depression with history of subthreshold 
hypomania  
 Minor subthreshold bipolar disorder: dysthymia, minor depression, or recurrent 
brief depression with history of subthreshold hypomania 
 Minor bipolar disorder: DSM-IV hypomania with or without history of dysthymia, 
minor depression, or recurrent brief depression 
Subthreshold hypomania was defined as a period of at least 4 days with the following: 1) 
elevated or expansive mood that created problems or was noticed by others, but not 
meeting symptom threshold for DSM-IV hypomania, or 2) unusually irritable mood 
expressed as starting arguments, shouting at or hitting people, and having at least three 
hypomanic symptoms, but symptoms were not observable by others. Minor depression 
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referred to depressive symptoms that did not meet criteria for a DSM-IV depressive 
episode. Of the 2,210 participants, Zimmermann et al. reported that 9% qualified for 
subthreshold bipolar disorder, 6% qualified for minor subthreshold bipolar disorder, and 
3% qualified for minor bipolar disorder. In comparison to a control group, the authors 
reported higher rates of suicide attempts, substance use disorders, and nicotine 
dependence in participants with subthreshold bipolar disorder. They reported a combined 
prevalence rate of 14% for the bipolar spectrum, which included bipolar I and II disorders 
and subthreshold bipolar disorder, and excluded the minor disorders. This is consistent 
with Angst et al. (2003), who reported a prevalence rate of 12% for bipolar I and II 
disorders and softly defined bipolar II disorder (major depression plus subthreshold 
hypomania). 
 Angst et al. (2010) examined the prevalence of major depression with 
subthreshold hypomania using data from the US NCS-R (Kessler & Merikangas, 2004). 
Criteria for subthreshold hypomania included failure to meet full diagnostic criteria for 
hypomania and endorsement of at least one of two screening questions: 
1)  “Some people have periods lasting several days or longer when they feel much 
more excited and full of energy than usual. Their minds go too fast. They talk a lot. 
They are very restless or unable to sit still and they sometimes do things that are 
unusual for them, such as driving too fast or spending too much money. Have you 
ever had a period like this lasting several days or longer?” 
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2)  “Have you ever had a period lasting several days or longer when most of the time 
you were so irritable that you either started arguments, shouted at people, or hit 
people?”     
Of the 5,692 participants, Angst et al. (2010) reported that 7% qualified for major 
depression with subthreshold hypomania. Moreover, 67% of these participants reported 
experiencing severe role impairment over the previous year, and another 25% reported 
experiencing moderate role impairment. Additionally, 41% of participants with major 
depression and subthreshold hypomania endorsed at least one suicide attempt during their 
lifetime and 35% qualified for a substance use disorder. Rates of substance use disorders 
among participants with major depression and subthreshold hypomania exceeded rates 
among participants with only major depression. Including bipolar I and II disorders and 
subthreshold bipolar disorder, the authors reported a 9% prevalence rate for the bipolar 
spectrum. 
Most recently, Hoertel et al. (2013) assessed the prevalence of major depression 
with subthreshold hypomania in a sample of 43,093 individuals who took part in the 
2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions 
(NESARC). Subthreshold hypomania was defined as failure to meet the full DSM-IV 
diagnostic criteria for hypomania and the presence of at least one of the following three 
criteria: 1) 1-week period of elevated mood that others noticed, 2) 1-week period of 
elevated mood that resulted in others being concerned, and/or 3) 1-week period of 
irritable mood (e.g., shouting at others, throwing or breaking objects, or starting fights or 
arguments). Under these diagnostic guidelines, Hoertel and colleagues reported that 3% 
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of participants met criteria for major depression with subthreshold hypomania. The 
authors also reported that these participants had higher 12-month psychiatric comorbidity 
rates of any Axis I disorder, substance use disorder, nicotine dependence, and dysthymia 
in comparison to participants with unipolar depression. The authors reported a combined 
prevalence of 6% for bipolar I and II disorders and subthreshold bipolar disorder. 
Overall, these studies suggest that the traditional lifetime prevalence rate for 
bipolar disorders of 1-2% is conservative and excludes individuals who experience 
subthreshold bipolar psychopathology and characteristics. Additionally, several studies 
(Angst et al., 2003, 2010; Hoertel et al., 2013; Merikangas et al., 2007; Zimmermann et 
al., 2009) found that subthreshold bipolar disorders were associated with maladaptive 
consequences (e.g., role impairment, suicide risk, substance use disorders, etc.). Taken 
together, these epidemiological studies offer evidence that the boundaries of bipolar 
psychopathology extend beyond those of the current diagnostic system. However, as is 
demonstrated by these studies, there is not a consensus regarding the exact 
conceptualization of broader bipolar disorders or whether these conditions are best 
considered within a categorical or dimensional framework.  
The relation of subthreshold symptoms with clinical disorders. There is 
considerable evidence that subthreshold bipolar psychopathology precedes the 
development of DSM bipolar disorders. Akiskal, Djenderedjian, Rosenthal, and Khani 
(1977) reported that nearly one-third of their sample of outpatients with cyclothymia 
developed bipolar I or II disorders within a 2-3 year period. More recently, Beesdo et al. 
(2009) examined the incidence patterns of mood episodes and conversion rates to bipolar 
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disorders in a sample of 3,021 community participants (aged 14-24 years at baseline) 
over a 10-year period. Among individuals with pure hypomania (no history of major 
depression at or prior to baseline), 16% subsequently experienced major depression and 
thus transitioned into bipolar II disorder. An additional 28% of individuals subsequently 
developed subthreshold depressive symptoms (i.e., “soft” bipolar II disorder).  
Using data from The Longitudinal Investigation of Bipolar Spectrum Disorders 
(LIBS) Project, Alloy, Urošević, et al. (2012) examined the course of bipolar spectrum 
disorders over a 4.5-year follow-up period in a sample of 206 college undergraduates 
with early onset (mean age of onset for first hypomanic or depressive episode or 
cyclothymic pattern was 13 years old). The authors reported that 42% of the participants 
initially identified as cyclothymic or bipolar NOS transitioned to bipolar II disorder and 
that 15% of participants with bipolar NOS, cyclothymic, or bipolar II disorders 
subsequently developed bipolar I disorder. In a younger sample of 413 youths (aged 7-17 
years) with bipolar spectrum disorders, Birmaher et al. (2009) reported that 25% of 
youths with bipolar II disorder converted to bipolar I disorder and 38% of youths with 
bipolar NOS converted to either bipolar I or bipolar II disorder over a 4-year period. 
Kochman et al. (2005) found that 64% of youth (mean age 13 years) with cyclothymic 
temperament and history of depression transitioned to bipolar II disorder over a 2-4 year 
follow-up period. Additionally, Zimmermann et al.’s (2009) 10-year prospective study 
found that individuals with a history of major depression and subthreshold hypomania 
were more likely to develop DSM-IV bipolar disorders in comparison to individuals 
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diagnosed with unipolar depression. Taken together, these studies indicate that 
subthreshold bipolarity often precedes the development of clinical disorders. 
Family studies. Family history has been described as an important external 
validator of psychopathology (Akiskal, 2003; Kraepelin, 1921; Robins & Guze, 1970). 
Akiskal et al. (1977) found nearly identical histories of first-degree relatives with bipolar 
disorders in bipolar I and cyclothymic probands (26% vs. 30%, respectively), with a 
control group of “pseudocyclothymic” participants reporting a rate of only 2%. Gershon 
et al. (1975) reported higher rates of cyclothymia in the relatives of bipolar I probands. 
Across participants with either DSM-IV or “soft” bipolar II disorder, Angst et al. (2003) 
reported comparable rates of mania (12% vs. 18%, respectively) and depression (60% vs. 
59%, respectively) among first-degree relatives. The combined family history of mania 
across both bipolar II groups was significantly higher than that of patients with major 
depressive disorder. Additionally, family history of mania among participants with pure 
hypomania (19%) was higher than in a control group (4%)—comparable to Angst (1998) 
who reported a 2-fold higher rate of family history of mania in participants with history 
of subthreshold hypomania in comparison to a control group. Cassano et al. (1992) found 
significantly higher rates of familial bipolarity among individuals with history of major 
depression and hyperthymic temperament (Akiskal’s bipolar IV) as compared to 
individuals with unipolar depression. Similarly, Zimmermann et al. (2009) found higher 
rates of mania in the family members of individuals with major depression and 
subthreshold hypomania in comparison to relatives of patients with unipolar depression 
and control group members.  
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Dimensional Models of the Bipolar Spectrum 
In light of the growing body of evidence for a broader bipolar spectrum, there is 
also growing support for dimensional models of bipolar psychopathology. Dimensional 
approaches are currently being considered for a range of psychological disorders, most 
notably personality disorders (e.g., Krueger, Derringer, Markon, Watson, & Skodol, 
2012; Widiger, Costa, & McCrae, 2012; Widiger, Livesley, & Clark, 2009), but also 
anxiety (e.g., Shear, Bjelland, Beesdo, Gloster, & Wittchen, 2008; Watson, 2009), 
substance use (e.g., Helzer, Bucholz, & Gossop, 2008), psychotic (e.g., Allardyce, 
Suppes, & van Os, 2008), and depressive (Andrews et al., 2008) disorders. Dimensional 
models provide rich, specific descriptions at the level of the individual that are more valid 
and consistent with the nature of psychopathology (Simonsen, 2010; Widiger, 2005). 
Specifically, dimensional models may avoid the “misleading, unstable, and illusory 
efforts to carve psychological functioning at nonexistent discrete joints” (Widiger & 
Samuel, 2005, p. 500). A dimensional profile of several clinical features will likely be 
more informative and representative of an individual’s presentation than a positive 
diagnosis, especially when one considers the heterogeneity within diagnostic categories. 
Furthermore, a dimensional model can easily be converted to a categorical diagnosis; 
however, the latter cannot be converted into dimensional scores (Widiger & Mullins-
Sweatt, 2007).  
Using dimensions in diagnosis allows for better exploration of differences 
between patients and improved representation of unusual cases (Simonsen, 2010). Within 
a categorical diagnostic system, drastically different symptom presentations may result in 
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the same diagnosis. Dimensional approaches offer the advantage of preserving 
differences across patients. Specifically, dimensional models offer gradations of illness 
along a continuum and allow for improved monitoring of changes in symptoms over time 
(Helzer, Kraemer, & Krueger, 2006; Simonsen, 2010). 
Dimensional approaches to psychopathology may also help elucidate the specific 
and nonspecific factors that comprise mental disorders. Within such a framework, 
individual disorders are represented as combinations of different symptoms, with some 
symptoms applying to a broad range of disorders (i.e., nonspecific factors), and other 
symptoms necessary for the diagnosis itself (i.e., specific factors), with few symptoms 
unique to a specific diagnosis. For example, neuroticism serves as a nonspecific factor for 
a range of disorders, including depression and anxiety (see Watson, O’Hara, & Stuart, 
2008), whereas anxious arousal serves as a specific factor for panic disorder (see Brown, 
Chorpita, & Barlow, 1998). As research in dimensional approaches progresses, Widiger 
and Clark (2000, p. 954) argue that it may make more sense conceptually to consider 
“symptom-cluster building blocks” with which to construct diagnoses—in contrast to a 
categorical set of diagnoses. Additionally, if specific symptom clusters are found to co-
occur at a high rate, future research may be able to identify an etiological basis for the co-
occurrence, and provide a meaningful categorical diagnosis. In summary, Widiger and 
Clark offer a bottom-up approach to diagnostic classification that may better map onto 
psychopathology as it exists in nature, and allow for increased understanding of etiology.  
Several researchers have attempted to characterize the bipolar spectrum using 
dimensional approaches. Katzow, Hsu, and Ghaemi (2003) proposed a dimensional 
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model that encompasses DSM-IV-TR bipolar disorders, subthreshold hypomania, and 
unipolar depression. Specifically, the authors (p. 439) offered a “smooth continuum” 
ranging from mania at the left pole and psychotic depression at the right, with 
hypomania, cyclothymia, subthreshold hypomania, euthymia, and mild, moderate, and 
severe depression falling in between. The authors stated that patients can cycle from any 
two points on the spectrum, including cyclicity confined to the depressive range, and 
argued that the “key” to bipolarity may be mood cycling in general, as opposed to 
polarity (i.e., cycling between mania and depression). Note that the notion of eliminating 
the requirement of polarity from the bipolar spectrum has been met with controversy 
(Phelps et al., 2008). 
Angst (2007) offered a comprehensive, two-dimensional model of the bipolar 
spectrum. Angst posited that the term ‘bipolar spectrum’ is used primarily to refer to two 
complementary ideas—a spectrum of severity and a spectrum of proportionality. Angst 
described each of these spectra as dimensional in nature, with no natural categorical 
subgroups, although Angst included categorical disorders within the model for 
descriptive purposes. Angst claimed that the spectrum of severity incorporated (from 
extreme to benign): psychotic major mood disorders, non-psychotic major mood 
disorders, minor bipolar disorders (e.g., hypomania with brief or mild depression), 
cyclothymic disorder, affective personality disorders (e.g., borderline personality 
disorder), affective temperaments (e.g., dysthymic, cyclothymic, and hyperthymic 
temperaments), “normal” ranges of functioning (i.e., isolated symptoms of hypomania 
and/or depression), and supernormal functioning (i.e., no mood symptoms). However, 
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Angst noted that the relationship between personality disorders and the bipolar spectrum 
remained unclear. Angst posited that the proportionality spectrum included the domains 
of depression and mania. Specifically, at the severity level of major mood disorders, it 
included: major depressive disorder, depression and hypomania (bipolar II), depression 
and mania (bipolar I), mild depression and mania, and pure mania. At the subthreshold 
level, Angst proposed that this spectrum included mild depression, minor bipolar 
disorders, and hypomania. In summary, Angst proposed a two-dimensional model of the 
bipolar spectrum that includes a range of clinical and subclinical experiences relevant to 
major depressive and bipolar disorders.  
Characteristics of Bipolar Spectrum Psychopathology 
Whether defined narrowly (e.g., DSM-IV-TR) or broadly, bipolar spectrum 
psychopathology involves dysregulation in affect, cognition, behavior, sense of self, as 
well as somatic disturbances. With regard to affect, bipolar spectrum psychopathology is 
characterized by euphoria and irritability, as well as lability of affect (American 
Psychiatric Association, 2000). Affective lability often includes shifts in both mood and 
energy (e.g., from energized euphoria to fatigue and dysphoria). Disruptions in cognition 
include changes in the form of thought, such as racing thoughts, fullness of thought, 
loosened associations, and distractibility, as well as changes in the content of thought, 
such as numerous (and often unrealistic) plans and goals. Changes in one’s sense of self 
may range from increased self-esteem to delusions of grandeur. Behavioral changes 
include increased energy and goal-directed behavior (e.g., socially, occupationally, and/or 
sexually), behavioral disinhibition and impulsivity, as well as pressured speech and 
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flights of ideas. Lastly, somatic changes include decreased need for sleep and 
psychomotor activation (e.g., restlessness and/or increased physical activity).  
 Grandiosity. Grandiosity is often associated with episodes of mania and 
hypomania at the more severe end of the bipolar spectrum. However, recent literature has 
also examined the extent to which more subtle expressions of grandiosity, such as 
overinflated expectations of success, are associated with the bipolar spectrum. Using a 
sample of college undergraduates psychometrically identified as at-risk for bipolar 
disorder by the HPS, Johnson and Carver (2006) examined the association of the HPS 
with highly ambitious life goals. They found that the HPS was positively associated with 
expectancies for popular fame (e.g. being friends with celebrities) and was modestly 
associated with aspirations for financial wealth (e.g., running a fortune 500 company), 
and political influence (e.g., being president of the country). The authors also noted 
small, but significant associations with goals related to creativity, world well-being (e.g., 
stopping world hunger), and idealized relationships with family and friends. The authors 
concluded that individuals at risk for bipolar disorder are likely to be sensitive to 
potential reward and have high ambition. Similarly, Eckblad and Chapman (1986) 
reported that high scorers on the HPS reported higher levels of ambition, artistic interests, 
and leadership, as well as increased likelihood of wealth and fame in comparison to a 
control group. Participants with elevated HPS scores were also more likely to endorse 
purposefully calling attention to themselves and to describe themselves as odd or 
different, compared to the control group.  
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Research has also examined the extent to which highly ambitious expectations 
contribute to risk for bipolar disorder. Using a sample of adolescents (aged 14-19 years) 
who scored in the moderate to high range on a measure of behavioral approach system 
sensitivity, Alloy, Bender, et al. (2012) reported that expectations for popular fame and 
wealth predicted shorter time to first onset of bipolar spectrum disorders. The authors  
argued that setting highly ambitious goals may reflect the same underlying traits of 
grandiosity observed in hypomania and mania.  
Similar findings have also been observed in clinical samples. Johnson, Eisner, and 
Carver (2009) found that lifetime history of a clinical bipolar disorder was associated 
with elevated expectations of popular fame and wealth. At the extreme end of the bipolar 
spectrum, Johnson, Carver, and Gotlib (2011) reported elevated ambitions of popular 
fame among individuals with bipolar I disorder in comparison to a control group. 
Impulsivity. Impulsivity is considered a core feature of bipolar psychopathology 
(American Psychiatric Association, 2000). In addition to impulsivity characteristic of 
manic episodes, such as substance use, spending sprees, reckless driving, and sexual 
indiscretions (American Psychiatric Association, 2000), trait-like impulsivity has also 
been reported to be higher among individuals with bipolar disorder. Specifically, 
individuals with bipolar disorder were found to have elevated rates of impulsivity, 
regardless of whether they were in a depressed (Peluso et al., 2007), manic (Swann, 
Pazzaglia, Nicholls, Dougherty, & Moeller, 2003), or euthymic mood state. Trait 
impulsivity has also been shown to be higher in the unaffected relatives of patients with 
bipolar I disorder (Lombardo et al., 2012). Alloy, Urošević, and colleagues (2012) found 
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that impulsivity (as measured by the Impulsive-Nonconformity Scale; Chapman et al., 
1984) predicted transition to bipolar I disorder among college students with early onset 
bipolar spectrum disorders, when controlling for family history and other covariates. 
Whiteside, Lynam, Miller, and Reynolds (2005) offered a multidimensional 
model of impulsivity based upon distinct personality pathways: urgency, lack of 
premeditation, lack of perseverance, and sensation seeking. Urgency refers to the 
tendency to act impulsively in the presence of negative affect. Impulsive behavior may 
serve as a way to cope with negative affect, despite its potential long-term negative 
consequences (Whiteside et al., 2005). Lack of premeditation refers to difficulty 
reflecting on a behavior and its potential consequences prior to engaging in it. Lack of 
perseverance refers to an inability to maintain focus on a task that one finds difficult or 
boring. Lastly, sensation seeking refers to a preference for activities that are exciting, and 
openness to experiences that may be dangerous. Walsh et al. (2012) found that HPS 
scores were positively associated with urgency, lack of premeditation, and sensation 
seeking, but not lack of perseverance in a sample of college students oversampled for 
elevated HPS scores 
Borderline personality disorder. Borderline personality disorder has also been 
examined in relation to bipolar spectrum psychopathology. Three recent reviews of the 
phenomenology of borderline personality and bipolar disorders indicated they are 
overlapping, yet distinct constructs (Antoniadis, Samakouri, & Livaditis, 2012; Coulston, 
Tanious, Mulder, Porter, & Malhi, 2012; Paris, Gunderson & Weinberg, 2007). 
Specifically, both borderline personality disorder and mood disorders are associated with 
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high neuroticism and low conscientiousness, although they are differentiated by harm 
avoidance, which is elevated in borderline personality disorder (Paris et al., 2007). 
Affective dysregulation is central to both bipolar and borderline personality disorders; 
however, the mood changes differ across the disorders (Antoniadis et al., 2012; Coulston 
et al., 2012; Paris et al., 2007). Bipolar disorder is associated with mood changes from 
depression to elation, whereas borderline personality disorder is associated with switches 
from euthymia to anxiety and anger, but rarely to elation, and depressive symptoms are 
experienced more intensely (Antoniadis et al., 2012). In addition, environmental 
stressors, particularly interpersonal events, appear to play a stronger role in the affective 
response among individuals with borderline personality disorder, compared to bipolar 
disorders (Antoniadis et al., 2012; Paris et al., 2007). All three reviews noted that 
impulsivity is associated with bipolar and borderline psychopathology; however, 
impulsivity associated with borderline personality disorder is more likely to involve 
frequent efforts to relieve psychological pain and include suicide attempts or gestures 
(Coulston et al., 2012; Paris et al., 2007). Additionally, impulsivity associated with 
bipolar disorder is likely to be influenced by cognitive disturbances, such as racing 
thoughts and distractibility (Coulston et al., 2012). Lastly, Antoniadis and colleagues 
found that several symptoms, including fear of abandonment, hostile behavior, and 
dependent relationships, are more prominent in borderline personality disorder. 
Schizotypy. There is also evidence to suggest that there is phenomenological 
overlap across bipolar disorders and schizotypy. Schizotypy is defined as a broad 
phenotype that encompasses schizophrenia, schizophrenia-spectrum disorders, the 
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prodrome, as well as subclinical characteristics (Claridge, 1997; Kwapil & Barrantes-
Vidal, 2012; Lenzenweger, 2010; Meehl, 1962). Schizotypy is conceptualized as a 
multidimensional construct, with positive and negative dimensions being the most 
replicated factors. Positive schizotypy is characterized by magical thinking, referential 
ideas, unusual perceptual experiences, as well as negative affect and affective 
dysregulation. Positive schizotypy has been shown to be associated with mood disorders 
(Kwapil, Barrantes-Vidal, & Silvia, 2008) as well as risk for bipolar disorder using the 
HPS (Kwapil et al., 2000). Additionally, several studies reported elevated rates of 
schizotypal personality disorder or schizotypal traits within relatives of patients with 
schizophrenia and relatives of patients with affective disorders (Coryell & Zimmerman, 
1989; Kety et al., 1994; Squires-Wheeler, Skodol, Basset, & Erlenmeyer-Kimling, 1989; 
Squires-Wheeler, Skodol, Friedman, & Erlenmeyer-Kimling, 1988). At the extreme end 
of the schizotypy continuum, family studies have suggested that schizophrenia and 
bipolar disorder may share some of the same susceptibility factors (e.g., Potash, 2006; for 
review, see Bramon & Sham, 2001), and Jones and Tarrant (1999) suggested there are 
shared developmental precursors across schizophrenia and affective disorders. 
Assessment of Bipolar Spectrum Psychopathology 
Eckblad and Chapman (1986) developed the self-report HPS to identify 
individuals who may be at risk for bipolar disorder. Specifically, the scale was designed 
to pick up mild, manic, trait-like functioning. Eckblad and Chapman assessed the validity 
of the HPS in a cross-sectional study of college students. High scorers (HPS group; n = 
40) and control participants (n = 40) were recruited and interviewed for the presence of 
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manic episodes, hypomanic episodes, depressive episodes, affective personality 
disorders, and substance use. Approximately 77% of the HPS group met criteria for a 
hypomanic episode, using the Schedule for Affective Disorders and Schizophrenia—
Lifetime Version (SADS-L; Spitzer & Endicott, 1977), whereas no control participants 
received the diagnosis. Furthermore, six of the nine individuals in the HPS group who did 
not receive a hypomanic diagnosis reported usually feeling euphoric or energetic. The 
HPS group also exceeded the control group on week-long depressive episodes, diagnoses 
of cyclothymic personality disorder and treatment of psychopathology, and reported 
significantly higher alcohol and drug use. Additionally, the HPS group endorsed 
significantly more schizotypal indicators and psychotic and psychotic-like experiences 
than the control group. Overall, these findings supported the relation of the HPS with 
bipolar spectrum psychopathology. 
A 13-year follow-up of this sample revealed similar group differences (Kwapil et 
al., 2000). At the follow-up assessment, participants were assessed for bipolar spectrum 
psychopathology, borderline personality disorder, schizotypal personality disorder, as 
well as impulsive-nonconformity. Twenty-eight percent of the HPS group met criteria for 
a DSM-IV hypomanic episode within the past two years, compared to 3% of the control 
group. Furthermore, 25% of the HPS group and none of the control group met criteria for 
DSM-IV bipolar disorders; two participants in the HPS group met criteria for bipolar I 
disorder and seven participants met criteria for bipolar II disorder. Thirty-six percent of 
the HPS group, compared to 10% of the control group, experienced a major depressive 
episode during the follow-up period. Forty-four percent of the HPS group, compared to 
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13% of the control group, met criteria for a substance use disorder during the follow-up 
period. Additionally, the HPS group exceeded the control group on dimensional scores of 
borderline personality disorder. The HPS group also exhibited elevated ratings of 
psychotic-like experiences or psychotic deviancy in comparison to the control group, and 
demonstrated a trend toward higher dimensional scores of schizotypal personality  
disorder. None of the participants met criteria for full diagnosis of borderline or 
schizotypal personality disorder. The groups did not differ with respect to treatment.  
The authors reported that HPS participants who scored highly on the Impulsive-
Nonconformity Scale (Chapman et al., 1984) at the time of the initial assessment (HPS-
impulsive group) had especially poor outcomes at the follow-up compared to participants 
who only experienced hypomanic personality. The Impulsive-Nonconformity Scale 
assesses an unwillingness to conform to society’s norms, a lack of empathy toward 
others’ suffering, as well as a tendency toward impulsive and self-gratifying behaviors 
(Chapman et al., 1984). Participants within the HPS-impulsive group experienced more 
bipolar disorder diagnoses than the remaining 27 individuals in the HPS group (67% 
compared to 11%). In addition, 22% of the HPS-impulsive group experienced manic 
episodes, compared to none of the individuals in the non-impulsive HPS group. 
Furthermore, 56% of the HPS-impulsive group reported being arrested compared to 15% 
of the non-impulsive HPS group. This group also exceeded the control group on 
borderline characteristics and alcohol use, and experienced lower overall psychosocial 
functioning. The authors suggested that the overlap between bipolar spectrum and 
borderline personality features could be attributed to affective dysregulation associated 
 
 
24 
 
with both constructs. Overall, the authors concluded that poor behavioral gating in 
combination with bipolar spectrum psychopathology contributed to an especially 
heightened risk for behavioral and social impairment, and the experience of clinical 
bipolar disorders.  
Walsh et al. (2012) examined the construct validity of the HPS as a measure of 
bipolar spectrum psychopathology in the laboratory and in daily life using experience 
sampling methodology (ESM) in a sample of 145 college students oversampled for 
elevated HPS scores. The authors reported that HPS scores were significantly associated 
with interview ratings of DSM-IV-TR bipolar disorders, Akiskal’s (2004) bipolar 
spectrum disorders, and hyperthymic temperament or history of hypomania. Fifteen 
(10%) of the participants met criteria for a DSM-IV-TR bipolar disorder (three with 
bipolar I, six with bipolar II, one with cyclothymic, and five with bipolar NOS disorders). 
Seven additional participants qualified for bipolar spectrum disorders. Note that 20 of the 
22 participants with diagnosable bipolar spectrum disorders scored at least 1.5 SD above 
the mean on the HPS. The relation of the HPS with history of major depressive episodes 
was not significant (despite the fact that major depressive episodes were part of many of 
the cases of bipolar disorders). HPS scores were positively associated with current 
depressive symptoms, poor psychosocial functioning, cyclothymic temperament, 
impulsivity (i.e., urgency, lack of premeditation, and sensation seeking), and symptoms 
of borderline personality disorder. In daily life, HPS scores were associated with negative 
affect, thought disturbance, risky behavior, and measures of grandiosity. These findings 
remained independent of DSM-IV-TR bipolar disorders, suggesting that the results were 
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not due simply to a subset of severely impaired participants with clinical bipolar 
disorders. However, Walsh et al.’s findings were limited to cross-sectional comparisons. 
Longitudinal assessment is needed to more fully assess the predictive validity of the HPS. 
Goals and Hypotheses 
The present research continued the validation work of Walsh et al. (2012) by 
examining the predictive validity of the HPS as a measure of bipolar spectrum 
psychopathology in a 3-year longitudinal study of their original sample. Specifically, this 
study examined whether the HPS predicts DSM bipolar disorders and bipolar spectrum 
psychopathology, as well as alcohol and drug use and impairment, borderline and 
schizotypal personality disorder symptoms, and psychosocial impairment over a 3-year 
period. This study also attempted to replicate and expand upon Kwapil et al.’s (2000) 
longitudinal findings that impulsivity moderates the relation of the HPS with adverse 
outcomes. Finally, this study provides a preliminary examination of the validity of a 
continuous rating system of bipolar spectrum psychopathology. Specific goals, 
hypotheses, methods, and analytic strategies are described in the subsequent sections.  
Relation of the HPS with Bipolar Spectrum Psychopathology 
The present study examined the relation of the HPS with: 1) DSM-IV-TR bipolar 
disorders, 2) bipolar spectrum disorders, 3) hypomanic episodes and hyperthymic 
temperament, 4) major depressive episodes, 5) grandiosity, 6) impulsivity, 7) alcohol and 
drug use and impairment, 8) borderline and schizotypal personality disorder symptoms, 
and 9) psychosocial functioning. In order to examine the extent to which the HPS 
predicted new cases of bipolar and bipolar spectrum disorders, major depressive 
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episodes, as well as hyperthymic temperament or history of hypomania at the follow-up 
assessment, these analyses were also computed after omitting participants diagnosed at 
the initial assessment. Specific hypotheses are outlined below.  
1a The HPS will predict DSM-IV-TR bipolar disorders in the follow-up sample and 
among participants who did not meet criteria for a bipolar disorder at the initial 
assessment.  
1b The HPS will predict bipolar spectrum disorders (including DSM-IV bipolar 
disorders) in the follow-up sample and among participants who did not meet criteria 
for a bipolar spectrum disorder at the initial assessment.  
1c The HPS will predict current hyperthymic temperament or history of hypomania in 
the follow-up sample and among participants who did not meet criteria for 
hypomania or hyperthymic temperament at the initial assessment. Similarly, the 
HPS is expected to predict hyperthymic temperament characteristics.  
1d The HPS will predict lifetime history of major depressive episodes in the follow-up 
sample and among participants who did not meet criteria for a lifetime major 
depressive episode at the initial assessment. The HPS is not expected to predict 
major depressive disorder.  
1e The HPS will predict grandiose characteristics.  
1f The HPS will predict impulsivity traits, specifically impulsive-nonconformity, 
urgency, lack of premeditation, and sensation seeking.   
1g The HPS will predict symptoms of borderline and schizotypal personality disorders. 
Given the relatively low base rate of these personality disorders and the young age 
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range of the participants, the HPS is not expected to predict elevated rates of full-
blown personality disorders. 
1h The HPS will predict current and heaviest alcohol use and impairment. 
Additionally, the HPS will predict current and heaviest drug use and impairment. 
These hypotheses are rather tentative, given that the HPS was not associated with 
alcohol or drug use in the cross-sectional study (Walsh et al., 2012); however, 
previous research (Eckblad & Chapman, 1986; Kwapil et al., 2000) supports a 
relation between the HPS and substance use, and bipolar spectrum disorders are 
often comorbid with substance use disorders (Angst et al., 2003, 2010; Hoertel et 
al., 2013; Zimmermann et al., 2009). 
1i The HPS will predict impairment in global, role, and social functioning. 
Relation of the HPS with Family History and Treatment History of 
Psychopathology 
The present study examined the relation of the HPS with interview measures of 
family history and treatment history of psychopathology. Specific hypotheses are 
outlined below. 
2a The HPS will predict family history of mood disorders. This hypothesis is rather 
tentative, given that the HPS was not associated with family history in the cross-
sectional (Walsh et al., 2012) or previous longitudinal research (Kwapil et al., 
2000). However, a number of studies (e.g., Akiskal et al., 1977; Akiskal & Benazzi, 
2006; Angst et al., 2003, Zimmermann et al., 2009) support the relation of bipolar 
spectrum psychopathology with family history of mood disorders. 
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2b The HPS will predict lifetime history of mental health treatment. This hypothesis is 
also rather tentative, given that the HPS was not associated with treatment history in 
the cross-sectional study (Walsh et al., 2012) or previous longitudinal research 
(Kwapil et al., 2000); however, the initial cross-sectional study of the HPS (Eckblad 
& Chapman, 1986) and epidemiological research (Angst et al., 2003) support the 
relation of bipolar spectrum psychopathology with treatment history.  
Relation of the HPS with Bipolar Spectrum Characteristics 
The present research offered a preliminary examination of the validity of a 
continuous rating system of bipolar spectrum characteristics. Specifically, bipolar 
spectrum characteristics were assessed across five domains, including disturbances in 
affect, behavior, cognition, sense of self, as well as somatic disturbances. In order to 
examine the extent to which the HPS was associated with a bipolar spectrum, the 
analyses were computed twice: first with the total sample and then with participants with 
DSM-IV-TR bipolar disorders omitted (identified either at the initial or follow-up 
assessment). The aim of this analytic strategy was to examine the hypotheses that 1) the 
HPS is associated with a spectrum of bipolar psychopathology, and that, 2) consistent 
with the notion that the spectrum includes subclinical manifestations, these associations 
will remain statistically significant after the participants with DSM-IV-TR bipolar 
disorders are omitted from the analyses. This allowed for the examination of whether the 
main effects predicted are largely driven by a subset of participants with bipolar disorders 
(and are no longer significant when these participants are omitted), or whether these 
effects remain even after these participants are excluded. It was hypothesized that the 
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HPS would predict lifetime history of disturbances in affect, behavior, cognition, sense of 
self, and somatic disturbances relevant to the bipolar spectrum both in the total sample 
and after removing participants with bipolar disorders. 
Moderating Effect of Impulsivity 
The present research examined the moderating effects of impulsivity on the 
relation of the HPS with adverse outcomes. All analyses were computed with the total 
follow-up sample. Urgency, sensation seeking, and risky behavior in daily life (as 
measured at the initial assessment) were expected to moderate the relation of the HPS 
with bipolar spectrum disorders and global functioning.
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CHAPTER II 
 
METHOD 
 
 
Participants 
 
Selection of Participants at the Initial Assessment 
 All of the candidate participants for the present study took part in Walsh et al.’s 
(2012) cross-sectional assessment. Approximately 1,200 students enrolled in psychology 
courses at the University of North Carolina at Greensboro completed the HPS in mass-
screening sessions during three consecutive semesters, beginning in the spring of 2008. A 
total of 191 students were invited to participate in Walsh et al.’s study. Specifically, all of 
the mass-screening participants who scored at least 1.5 SD above the mean on the HPS 
and a comparable number of randomly selected participants who scored less than 1.5 SD 
above the mean were invited to participate. This recruitment strategy was designed to 
ensure that a sufficient number of individuals with bipolar spectrum psychopathology 
were included in the study, while maintaining a continuous distribution. A total of 147 
participants were enrolled. Two participants were dropped due to invalid questionnaire 
measures. The final sample included 100 women and 45 men. Mean age was 19.5 years 
(SD = 2.3 years). Neither age nor sex was significantly correlated with HPS scores (r =    
-.09 and -.02, respectively). The sample was 65% Caucasian, 16% African American, 4% 
Hispanic, 4% Asian/Pacific Islander, 4% other, and 7% unspecified.  
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Participation in the Follow-Up Assessment 
All 145 participants were invited to participate in the present study. The 
reassessment began in spring 2011 and is ongoing. Participants received $25 for their 
participation. Thus far, 100 participants (69% of the original sample) have completed the 
follow-up assessment, including 66 women and 34 men. Mean age was 22.5 years (SD = 
2.7 years).
1
 The mean time between assessments was 3.0 years (SD = 0.4 years, range = 
1.7 to 4.2 years). Of the 45 participants who were not reassessed thus far, 17 expressed 
interest but had not yet been scheduled, 13 declined to participate, 13 were not located, 
and 2 did not respond to recruitment efforts. There were no significant differences 
between the initial sample, follow-up sample, and non-followed sample with respect to 
HPS score, bipolar spectrum diagnoses, global functioning, or demographic variables, as 
measured at the initial assessment (see Table 1).   
Materials and Procedures 
Measures Administered at the Initial Assessment 
As described in Walsh et al. (2012), participants completed interview, 
questionnaire, and ESM assessments at the initial evaluation. Note that the interview at 
the initial assessment was comparable to the interview administered at the follow-up 
(described below). Participants completed the HPS (Eckblad & Chapman, 1986), which 
consists of 48 true-false items that were worded to reflect either stable characteristics or 
recurrent experiences. The HPS was administered on two occasions: at a mass-screening 
session and at the time of the cross-sectional assessment (2 to 12 weeks apart, mean = 5.5 
                                                 
1
 At the time of the submission of the dissertation to committee members, an additional 10 participants had 
been interviewed (for a total of 110). 
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weeks). The scores were examined at both time points (mass-screening HPS: mean = 
22.6, SD = 11.0, range = 3 to 42; interview HPS: mean = 17.5, SD = 10.0, range = 0 to 
41). The lower mean HPS score at the second time point likely reflected regression to the 
mean (especially given the selection procedure). HPS scores were strongly correlated 
across the two time points (intraclass correlation coefficient = .85, p < .001); therefore, 
participants were assigned an average HPS score for all analyses (simply referred to as 
the HPS score). Coefficient alphas for the HPS completed at mass-screening and at the 
time of the cross-sectional assessment were .83 and .93, respectively. 
Participants completed the UPPS Impulsivity Scale (Whiteside & Lynam, 2001; 
Whiteside et al., 2005) during the initial and follow-up assessments. The UPPS is a 46-
item scale designed to measure four distinct personality pathways to impulsive behavior: 
urgency, lack of premeditation, lack of perseverance, and sensation seeking. Each item is 
rated on a 4-point scale ranging from 1 = “agree strongly” to 4 = “disagree strongly.” 
Coefficient alphas for the UPPS completed at the initial assessment were .89, .83, .87, 
and .87 for urgency, lack of premeditation, lack of perseverance, and sensation seeking, 
respectively. 
During the initial assessment, experience sampling methodology (ESM) was used 
to assess risky behavior in daily life. Participants carried a Palm Pilot PDA that 
administered three questions tapping risky behavior (as part of a 31-item protocol) for 7 
days. The ESM protocol was based upon work by Kwapil et al. (2010). Items assessing 
risky behavior included, “I am doing something risky right now,” “I am doing something 
right now that I might regret later,” and “My behavior right now could get me into 
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trouble.” All of the items were scored on a 7-point scale from “not at all” to “very much.” 
The PDAs signaled the participants, administered the questionnaires, and time-stamped 
and recorded the participants’ responses. Participants were signaled to complete the ESM 
questionnaire eight times daily between noon and midnight during their study 
participation. The three risky behavior items correlated highly (mean r = .86) and a 
composite variable was formed by computing the mean of the aggregate score (the mean 
of all time points) across the three items for each participant. 
Measures Administered at the Follow-Up Assessment 
The present study included a structured interview that assessed DSM-IV-TR mood 
disorders, bipolar spectrum disorders, bipolar spectrum characteristics, alcohol and drug 
use, grandiose traits, borderline and schizotypal personality disorder symptoms, 
psychosocial functioning, lifetime history of mental health treatment, and family history 
of psychopathology. Ninety-one percent of the interviews were conducted by an 
advanced graduate student in clinical psychology who had previously conducted 95 
interviews and ratings as part of the initial assessment reported in Walsh et al. (2012). A 
licensed clinical psychologist completed 5% of the interviews and a trained 
undergraduate research assistant completed 4% of the interviews. All interviews were 
tape-recorded and took approximately 1-2 hours.  
Mood disorders. The Structured Clinical Interview for DSM-IV (SCID-I; First, 
Spitzer, Gibbon, & Williams, 1996) was used to assess mood episodes and disorders. 
Bipolar spectrum disorders were diagnosed based upon criteria reported in Akiskal 
(2004) and Angst et al. (2003) using information obtained from the SCID-I interview. 
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The SCID-I was appropriate for diagnosing clinical bipolar disorders, as well as bipolar II 
½ (major depression superimposed on cyclothymic temperament) and bipolar III (major 
depression plus treatment-induced hypomania). Using Akiskal’s criteria, participants 
were interviewed for the presence of hyperthymic temperament to determine diagnoses of 
bipolar IV (major depression superimposed on hyperthymic temperament). Participants 
received scores of 0 (not present), 1 (subthreshold), or 2 (threshold) across 9 items 
measuring hyperthymic characteristics: upbeat/exuberant mood, articulate/jocular, 
overoptimistic and carefree, overconfident and boastful, high energy level/full of plans, 
versatile with broad interests, overinvolved and meddlesome, uninhibited and risk-taking, 
and short sleeper (<6 hours/night). Participants with hyperthymic temperament and 
subthreshold depression (e.g., depressive episode not meeting DSM-IV-TR symptom or 
duration threshold or recurrent brief depression), as well as participants with past 
hyperthymic temperament and hypomania received a diagnosis of “other bipolar 
spectrum disorder.” Following Angst et al. (2003), participants were also coded with 
“other bipolar spectrum disorder” if they endorsed hypomania and subthreshold 
depression (e.g., depressive episode not meeting DSM-IV-TR symptom or duration 
threshold or recurrent brief depression), or major depression and subthreshold 
hypomania. Subthreshold hypomania was defined as a hypomanic episode lasting at least 
2 days and characterized by affective disturbance or overactivity (e.g., increased goal-
directed behavior, psychomotor activation, increased talkativeness, decreased need for 
sleep, and/or racing thoughts) that did not meet DSM-IV-TR duration and/or symptom 
threshold.  
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Bipolar spectrum characteristics. The interview also assessed subclinical bipolar 
spectrum psychopathology using a continuous rating system. Additional prompts were 
incorporated into the SCID-I to obtain dimensional information regarding bipolar 
psychopathology. The rating system provided quantitative ratings of current and lifetime 
most severe episodic bipolar spectrum characteristics across five domains: disturbances 
in affect, behavior, cognition, sense of self, and somatic disturbances. Episodes in these 
domains had to have a minimum duration of 2 days, represent a departure from one’s 
usual functioning, and could not be the result of a normative life experience, alcohol or 
drug use, or general medical condition. Note that episodes induced by antidepressant 
medications were rated. In order for an episode to qualify for a rating, affective 
disturbance or overactivity had to be present. Following the recommendations of Angst et 
al. (2003, 2012), participants who reported at least one overactivity symptom without a 
disturbance in affect were rated. Note that each of the five domains consisted of several 
underlying bipolar spectrum characteristics. Specifically, disturbances in affect included 
episodes of euphoria, irritability, and cyclothymia. Disturbances in behavior referred to 
increased goal-directed activity, increased talkativeness, and risky behavior. Disturbances 
in cognition included racing thoughts and distractibility. Disturbance in sense of self 
referred to increased self-esteem, and somatic disturbances included decreased need for 
sleep and psychomotor activation. Participants received a rating according to the severity 
of their experiences for each characteristic using the following scale: 0 (not present), 1 
(mild, subclinical), 2 (moderate, consistent with hypomania), 3 (severe, consistent with 
hypomania/mania with impairment), and 4 (extreme, consistent with severe mania 
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including psychotic features). All items included a description for each anchor point. 
Participants received a lifetime rating for each domain that was based on the most severe 
lifetime rating they received across all characteristics within each domain. 
Grandiosity. Following Eckblad and Chapman (1986), the interview included an 
8-item assessment of grandiosity. Using a Likert scale, participants were asked to rate the 
likelihood that they would become famous or be featured on the cover of a magazine, as 
well as their level of ambition, creativity, and extent to which they felt that they were odd 
or different from their peers. Participants were also questioned about whether they had 
done things to call attention to themselves or considered themselves to be leaders or 
followers. 
Impulsivity. In addition to re-administering the UPPS, the Impulsive-
Nonconformity Scale (Chapman et al., 1984) was administered at the follow-up 
assessment. The scale includes 51 true-false items designed to measure stable traits, 
specifically lack of concern for others’ rights or feelings, lack of respect for social norms 
and ethical standards, hostility and lack of remorse for others’ injuries, lack of empathy, 
and unrestrained pursuit of self-gratification. Chapman and colleagues reported 
coefficient alphas of .84 for males and .83 for females and test-retest reliability across six 
weeks of .84 across both sexes.  
Substance use. The interview assessed participants for DSM-IV-TR substance 
abuse and dependence using the system reported in Kwapil (1996). In addition to 
providing DSM-IV-TR substance use disorder diagnoses, the rating system provided 
quantitative ratings of the current and lifetime heaviest frequency and quantity of 
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substance use and impairment related to use and abuse. Participants were rated on the 
frequency of current and heaviest alcohol usage on a scale from 0 (none) to 5 (more than 
3 times per week), and on the quantity of alcohol consumed per day on a scale from 0 
(none) to 4 (more than 8 beers, glasses of wine, or shots of liquor). The product of 
frequency and quantity (score of 0 to 20) produced measures of current and heaviest 
usage of alcohol. Participants were also rated on current and highest impairment in 
functioning caused by alcohol use on a scale from 0 (none) to 5 (major life disruptions). 
Participants were rated on current and heaviest drug use separately on scales ranging 
from 0 (none) to 4 (excessive use) for cannabis, amphetamines, sedatives, and inhalants; 
from 0 (none) to 6 (excessive use) for cocaine, phencyclidine (PCP), and hallucinogens; 
and from 0 (none) to 8 (at least twice per month with stronger drugs) of opioids. The 
rating scales reflect frequency and quantity of use, and they differ to reflect the 
seriousness of the substances. The ratings for each substance were summed to produce 
measures of current and heaviest drug use (scores of 0 to 42). Likewise, the participants 
were rated on current and highest impairment in functioning caused by drug use on a 
scale from 0 (none) to 5 (major life disruptions).  
 Psychosocial functioning. Participants’ current psychosocial functioning was 
examined using the global assessment of functioning (GAF), as described in the DSM-
IV-TR. GAF scores, which range from 1 (grossly impaired functioning) to 100 (superior 
functioning) are based on an individual’s psychological, social, and occupational 
functioning. Additionally, participants’ functioning was measured using Cornblatt et al.’s 
(2007) global functioning scales. The scales were designed to measure social and role 
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functioning in the prodromal phase of psychosis; however, Cornblatt et al. suggested that 
the scales are applicable to comparable at-risk populations. Average intraclass correlation 
coefficients reflecting cross-site interrater reliability for current social and role 
functioning were .85 and .93, respectively. Social functioning scores range from 1 
(extreme social isolation) to 10 (superior social/interpersonal functioning). Similarly, role 
functioning scores range from 1 (severe role dysfunction) to 10 (superior role 
functioning). 
 Borderline and schizotypal personality disorders. Borderline and schizotypal 
personality disorders were assessed using the International Personality Disorder 
Examination (IPDE; Loranger et al., 1994). The IPDE is a widely used personality 
disorder interview and the only one based on worldwide field trials. The overall interrater 
reliability kappas of the borderline and schizotypal personality disorder sections of the 
IPDE are reported to be .89 and .82 for the number of criteria met, and .93 and .87 for the 
dimensional score, respectively. The overall temporal stability coefficients for borderline 
and schizotypal personality disorders are reported to be .84 and .69 for the number of 
criteria met, and .87 and .81 for the dimensional score, respectively (Loranger et al., 
1994).   
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CHAPTER III 
 
RESULTS 
 
 
Statistical analyses were computed using SPSS 19.0 (IBM Corp., 2010). Binary 
logistic regression was used to examine the relation of the HPS with dichotomous 
measures, such as diagnoses of psychopathology. Pearson correlations were used to 
analyze the relation of the HPS with quantitative variables. Binary logistic and linear 
regression analyses were used to examine the moderating role of impulsivity assessed at 
the initial assessment (using UPPS and ESM ratings) on the relation of the HPS with 
adverse outcomes. The moderator (e.g., urgency) and HPS scores were entered 
simultaneously into the regression equation at the first step, so the effects of each were 
assessed with the other partialled out of the equation. Their interaction term was entered 
at a second step to examine its effect over-and-above the partialled main effects. 
Consistent with the recommendations of Aiken and West (1991), the moderator and HPS 
scores were centered by subtracting the sample mean from all participants’ scores.    
Relation of the HPS with Bipolar Spectrum Disorders and Dichotomous Measures 
of Psychopathology at the Follow-up Assessment 
Table 2 provides a summary of diagnostic outcomes at the follow-up relative to 
diagnostic status at the initial assessment. Of the 123 participants who did not receive a  
bipolar diagnosis at the initial assessment, 85 were reassessed at the follow-up. Thirteen 
of these 85 participants (15% of the participants without bipolar disorders at the initial
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assessment) presented with new cases of bipolar spectrum disorders at the follow-up. 
Specifically, three participants received a DSM bipolar diagnosis and 10 participants 
received a non-DSM bipolar diagnosis. Nine of the 15 participants diagnosed with a 
DSM bipolar disorder at the initial assessment were reassessed at the follow-up. Six of 
these participants retained DSM bipolar diagnoses, two were given a non-DSM bipolar 
diagnosis, and one no longer met criteria for a bipolar diagnosis. This participant 
endorsed cyclothymic temperament, past depression, and borderline personality traits at 
the initial assessment (and was diagnosed with both cyclothymic disorder and bipolar II 
½). At the follow-up, she exhibited borderline personality traits (qualifying for 4 of 9 
criteria), but no longer exhibited cyclothymic temperament and therefore did not meet 
criteria for a bipolar spectrum diagnosis. Of the seven participants diagnosed with a non-
DSM bipolar disorder at the initial assessment, six were reassessed at the follow-up. Four 
of these participants retained non-DSM bipolar diagnoses, one transitioned to a DSM 
bipolar disorder, and one no longer met criteria for a bipolar diagnosis (the participant 
noted above).  
A total of 26 of the 100 reassessed participants met criteria for a bipolar spectrum 
disorder at the follow-up. Ten participants qualified for a DSM bipolar disorder and 16 
qualified for a non-DSM bipolar disorder. The 10 participants who met criteria for DSM 
bipolar disorders included two with bipolar I disorder, five with bipolar II disorder, and 
three with bipolar NOS disorder. Participants classified as bipolar NOS all exhibited 
current hyperthymic temperament and history of hypomania. Among the 16 participants 
diagnosed with non-DSM bipolar disorders at the follow-up, 12 qualified for bipolar IV 
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disorder and four qualified for “other bipolar spectrum disorder.” The four participants 
classified as “other bipolar spectrum disorder” included two participants with current 
hyperthymic temperament and history of subthreshold depression, one participant with 
history of subthreshold hypomania characterized by overactivity and major depression, 
and one participant with past hyperthymic temperament and history of hypomania. As 
noted, 13 of the 26 cases of bipolar spectrum disorder represented new cases. Of these 
cases, one participant qualified for bipolar II disorder, two qualified for bipolar NOS, 
seven qualified for bipolar IV disorder, and three qualified for “other bipolar spectrum 
disorder.”  
Table 3 presents the prediction of dichotomous indicators of bipolar 
psychopathology at the follow-up by HPS scores at the initial assessment. The HPS 
significantly predicted total number of DSM bipolar and bipolar spectrum disorder cases 
at the follow-up. Figure 1 presents the percentage of cases across HPS score quartiles. As 
seen in the figure, rates of DSM and broad bipolar disorders increased across these 
quartiles.  
The HPS predicted new cases of bipolar spectrum disorders at the reassessment, 
OR = 1.13, p < .01, 95% CI [1.05, 1.22]. Excluding the 15 participants who qualified for 
a bipolar spectrum disorder at the initial assessment, 13 participants (15% of the 
remaining 85 participants) transitioned to a bipolar spectrum disorder. Thus, the HPS did 
not simply identify deviant participants who qualified for bipolar spectrum disorders at 
the initial assessment, but also predicted development of new cases. However, the HPS 
did not specifically predict new cases of DSM bipolar disorders, OR = 1.11, p = .10, 95% 
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CI [0.98, 1.27]. Excluding the nine participants who met criteria for a bipolar disorder at 
the initial assessment, four participants (4% of the remaining 91 participants) transitioned 
to a DSM bipolar disorder. 
Table 3 also presents the association of the HPS with current hyperthymic 
temperament or history of hypomania, major depressive episodes, substance use 
disorders, mental health treatment, and family history of mood disorders in the follow-up 
sample. The HPS predicted current hyperthymic temperament or history of hypomania, 
with 34% of participants qualifying for one or both conditions (see Figure 2). The HPS 
also predicted current hyperthymic temperament or history of hypomania among 
participants who did not qualify for either condition at the initial assessment, OR = 1.26, 
p < .001, 95% CI [1.13, 1.40]. The HPS was not associated with history of major 
depressive episodes, and was associated with a decreased likelihood of development of 
major depressive disorder. The latter presumably indicates that high HPS scorers are 
specifically at risk for bipolar, not unipolar, mood disorders. The fact that high HPS 
scores were associated with bipolar disorders was not due to the fact that HPS scores 
were selectively associated with depression, as major depressive episodes occurred at 
comparable rates across the HPS quartiles. The HPS did not predict new major depressive 
episodes, OR = 1.01, p = .80, 95% CI [0.94, 1.08], or new cases of major depressive 
disorder at the follow-up, OR = 0.98, p = 0.64, 95% CI [0.91, 1.06]. The HPS predicted 
diagnoses of alcohol abuse or dependence at the follow-up assessment, with 12% 
qualifying for an alcohol use disorder. Additionally, the HPS predicted the development 
of alcohol abuse or dependence in participants who did not qualify for either condition at 
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the initial assessment, OR = 1.08, p < .05, 95% CI [1.01, 1.15]. Of note, 50% percent of 
participants with alcohol use disorders were also diagnosed with a bipolar spectrum 
disorder, and all of these cases fell in the upper 2 quartiles of HPS scores. Similarly, the 
HPS predicted drug abuse or dependence at the follow-up assessment, with 18% of 
participants meeting criteria for one of the conditions. The HPS also predicted new cases 
of drug abuse or dependence, OR = 1.09, p < .05, 95% CI [1.01, 1.17]. Furthermore, 44% 
of cases with history of drug abuse or dependence were diagnosed with bipolar spectrum 
disorders, and the majority of these cases (75%) fell in the upper quartile of HPS scores. 
HPS scores at the initial assessment were not associated with history of mental 
health treatment. However, 60% of participants with DSM bipolar disorders and 58% of 
participants with bipolar spectrum disorders reported a history of mental health treatment. 
HPS scores did not predict the report of a family history of mood disorder. 
Relation of the HPS with Continuous Measures of Psychopathology at the  
Follow-Up Assessment 
Table 4 presents the zero-order correlations of the HPS with continuous measures 
of psychopathology in the total follow-up sample and after removing participants with 
DSM bipolar disorders. The HPS predicted hyperthymic temperament characteristics in 
the full sample, as well as in participants without DSM bipolar disorders. HPS scores 
were inversely associated with psychosocial functioning as assessed by the GAF in the 
total sample (see Figure 3) and the non-disordered subsample. Given that GAF was rated 
at both assessments, the regression analysis was recomputed partialling out GAF score at 
the initial assessment. Not surprisingly, functioning at the initial assessment was 
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significantly associated with functioning at the follow-up (β = .551, p < .001). However, 
the HPS significantly predicted impairment at the follow-up, over-and-above baseline 
GAF (β = -.181, p < .05). The HPS was not significantly associated with impairment in 
role functioning or social functioning. However, these measures were designed to be 
most sensitive to marked impairment seen in psychotic patients and may not have been 
sufficiently discriminant for a relatively high functioning sample. 
As hypothesized, the HPS predicted borderline and schizotypal personality 
disorder traits, although none of the participants met full criteria for either personality 
disorder diagnosis. Analysis of the individual traits indicates that the HPS significantly 
predicted the borderline traits of unstable self-image and relationships, impulsivity, and 
transient paranoia/dissociation, but not the items associated with affective instability, 
suicidal gestures, emptiness, fear of abandonment, or inappropriate anger. There was 
good stability of ratings of borderline personality criteria met and dimensional scores 
across the initial and follow-up assessments. The number of borderline criteria met at the 
two assessments correlated .75 and dimensional scores correlated .68 across the two 
assessments. However, these associations must be interpreted in light of the fact that the 
majority of the participants (75%) did not meet any borderline personality disorder 
criteria at either assessment, although the correlation of number of criteria met at the two 
assessments was .52 (a large effect size) when limited to the 25 participants who met at 
least one criteria at either assessment.  
In terms of schizotypal traits, the HPS significantly predicted odd beliefs, unusual 
perceptual experiences, and oddities of thought, speech, behavior and appearance, but not 
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the negative schizotypal traits. The HPS predicted impulsivity symptoms, specifically 
impulsive-nonconformity, urgency, lack of premeditation, and sensation seeking. 
Additionally, the HPS predicted grandiose traits, including predictions of future fame or 
being on the cover of a magazine, as well as appraisals of ambition, leadership, creativity, 
oddness, and tendency to draw attention to oneself. The HPS predicted current and 
heaviest alcohol use and impairment, and current and heaviest drug use and impairment. 
With the exception of borderline personality traits, all of these associations were 
significant after removing individuals diagnosed with DSM bipolar disorders at the 
follow-up assessment. Thus, the results overall do not appear to be driven by a subset of 
deviant participants.  
Zero-order correlations also examined the extent to which the HPS predicted 
hyperthymic temperament characteristics across participants with and without bipolar 
spectrum disorders (Table 5). The HPS predicted the total score for hyperthymic 
temperament characteristics across participants in three groups: 1) total follow-up 
sample, 2) reduced sample with DSM bipolar disorders removed, and 3) reduced sample 
with all bipolar spectrum disorders removed. With the exception of the short sleeper 
characteristic, the HPS predicted hyperthymic temperament characteristics in the total 
and reduced follow-up samples. This suggests that overall the HPS taps hyperthymic 
temperament characteristics independent of bipolar spectrum diagnoses. 
Table 6 illustrates the associations of the HPS with lifetime history of bipolar 
spectrum characteristics, as assessed by the dimensional rating system. The HPS 
predicted lifetime history of disturbance in affect, behavior, cognition, and sense of self 
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in the total sample. However, these associations were not significant after removing 
participants who met criteria for a clinical bipolar disorder at the follow-up assessment. 
Additionally, the HPS did not predict somatic disturbances in the total or reduced sample. 
Moderating Role of Impulsivity 
Tables 7 and 8 present the moderating effect of urgency, sensation seeking, and 
risky behavior in daily life measured at the initial assessment on the relation of the HPS 
with bipolar spectrum disorders and global functioning, respectively, at the follow-up 
assessment. Although there were significant main effects, none of the interactions were 
significant, indicating that contrary to hypotheses, impulsivity did not moderate the 
effects of the HPS.  
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CHAPTER IV 
 
DISCUSSION 
 
 
Predictive Validity of the HPS 
 The present research examined the predictive validity of the HPS as a measure of 
bipolar spectrum psychopathology in a nonclinically ascertained sample of young adults 
at a 3-year follow-up assessment. The HPS predicted new cases of bipolar spectrum 
disorders, with a striking 15% transition rate over the follow-up period (nearly doubling 
the number of cases reported at the initial assessment). The HPS appears to specifically 
predict bipolar mood disorders, as it was not a significant predictor of unipolar mood 
disorders. Additionally, the HPS predicted clinical bipolar disorders and a range of 
bipolar spectrum psychopathology, including hyperthymic temperament characteristics, 
measures of grandiosity and impulsivity, substance use disorders, as well as borderline 
and schizotypal personality traits. Overall, the HPS predicted bipolar spectrum 
psychopathology even after removing participants with DSM bipolar disorders, 
suggesting that the results were not driven solely by a subset of participants with clinical 
disorders.  
The HPS identified 13 new cases of bipolar spectrum disorders—15% of 
participants who did not qualify for a bipolar diagnosis at the initial assessment. Thus, the 
HPS identified new cases of bipolar spectrum psychopathology and did not simply re-
classify deviant participants identified at the initial assessment. The HPS primarily
 
 
48 
 
identified bipolar spectrum cases characterized by mood episodes combined with 
hyperthymic temperament. Therefore, these results offer support for Akiskal’s (2004) 
inclusion of hyperthymic temperament within the bipolar spectrum, as well as the 
construct of a bipolar spectrum that extends beyond the current diagnostic boundaries. 
Furthermore, the results provide support for the predictive validity of the HPS as a 
measure of the broader bipolar spectrum.  
The HPS predicted hyperthymic temperament characteristics irrespective of 
bipolar diagnosis. Specifically, the HPS captured trait-like upbeat mood and high energy 
among individuals with bipolar spectrum disorders and individuals without a bipolar 
diagnosis. These results suggest that the HPS identifies a broad range of bipolar spectrum 
psychopathology that includes individuals with hyperthymic characteristics who exhibit 
adaptive functioning, as well as individuals with hyperthymic characteristics who exhibit 
psychosocial impairment within the context of bipolar spectrum disorders. Furthermore, 
these results offer support for the notion that hyperthymic temperament is associated with 
both adaptive and maladaptive characteristics (Akiskal et al., 2000). For example, the 
upbeat mood, sociability, versatility, decreased need for sleep, and high energy associated 
with the temperament are likely adaptive qualities, whereas the aspects of the 
temperament associated with engagement in risky behaviors, over-involvement in 
activities, grandiose confidence, and carefree optimism may be maladaptive. In the 
present study, maladaptive aspects of the temperament were not unique to participants 
with bipolar spectrum disorders, nor were adaptive qualities specific to patients without 
them. Overall, these findings suggest that hyperthymic characteristics are distributed 
 
 
49 
 
across participants with and without bipolar disorders—and that the HPS identifies both 
groups.  
The HPS predicted DSM bipolar disorders. Overall, 10% of the sample met 
criteria for a bipolar disorder. However, this was limited to participants with elevated 
HPS ratings and the rate was the highest (29%) in the upper quartile of HPS scorers, as 
illustrated in Figure 1. Note that this rate is actually higher than the 25% rate of DSM 
bipolar disorders reported for high HPS scorers in Kwapil et al.’s (2000) 13-year 
prospective study. The HPS did not significantly predict new cases of DSM bipolar 
disorders in the present study. However, the overall rate of bipolar disorders and the 
transition rate to bipolar spectrum disorders are striking given that the majority of 
participants in this sample have not yet reached the peak age of onset for DSM bipolar 
disorders. Using a large clinical sample of adults with bipolar I and II disorders across six 
international sites, Baldessarini et al. (2010) reported the median onset-age across 
disorders to be 25.2 years. As noted, the mean age of participants in the present research 
was 22.5 years. Therefore, we would expect continued transition to clinical bipolar 
disorders among the high HPS scorers. Of note, the mean age of participants in Kwapil et 
al.’s prospective study was 31.8 years, well beyond the median age of onset for bipolar 
disorders. The present study’s 29% rate of bipolar disorder (across the upper quartile of 
HPS scorers) therefore is striking given that it exceeds the rate reported in Kwapil et al. 
using a considerably younger sample that has not yet reached the peak age of onset.  
The HPS was associated with a decreased likelihood of major depressive disorder 
and was not associated with major depressive episodes. The present research suggests 
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that the HPS differentiates between bipolar and unipolar psychopathology, with the HPS 
predicting the former, but not the latter (in fact only one participant in the upper quartile 
of HPS scores developed [unipolar] major depressive disorder). Specifically, major 
depressive episodes were reported by participants across the entire range of HPS scores. 
However, participants with low HPS scores exhibited unipolar major depression (with 
over 93% of cases of major depressive disorder falling in the lower 2 quartiles of HPS 
scores), whereas participants with high HPS scores exhibited depressive episodes as part 
of a bipolar presentation. Overall, these findings provide additional evidence that the HPS 
is a valid measure of risk for bipolar spectrum psychopathology, not simply a measure of 
broad risk for mood disorders. 
 The HPS predicted measures of grandiosity, including perceptions of future fame 
or being on the cover of a magazine, and perceptions of current ambition, leadership, 
creativity, oddness, and tendency to draw attention to oneself. Participants who endorsed 
future fame were also questioned regarding how they would become famous, with 
anecdotal responses ranging from becoming a talk show host to a millionaire filmmaker. 
These findings replicate and expand upon Eckblad and Chapman’s (1986) cross-sectional 
results. Specifically, they suggest that the HPS predicts grandiose traits over time, and 
that grandiose traits are not specific to individuals with clinical bipolar disorders. The 
HPS was associated with grandiosity in the total sample, as well as in a reduced sample 
with DSM bipolar disorders removed. Therefore, grandiose traits seem to be apparent 
across the bipolar spectrum. These results also build on Johnson and Carver’s (2006) 
findings, which documented the association of the HPS with highly ambitious goals, 
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including popular fame. Following Alloy, Bender, et al. (2012), future research could 
examine the extent to which specific grandiose traits assessed at this follow-up predict or 
moderate the onset of bipolar spectrum disorders or other deleterious outcomes. 
 The HPS predicted new cases of substance use disorders, as well as alcohol and 
drug use and impairment. These findings are consistent with a number of studies that 
have documented an association between bipolar spectrum disorders and substance use 
(e.g., Angst et al., 2003, 2010; Hoertel et al., 2013; Zimmermann et al., 2009), and are 
consistent with Kwapil and colleagues’ (2000) finding that high HPS scorers had 
significantly higher rates of substance use disorders in comparison to a control group. It 
is worth noting that the HPS was not associated with substance use disorders and was 
generally unassociated with ratings of substance use at the initial assessment. Overall, the 
results offer further validation of the association between substance use and the broader 
bipolar spectrum, as well as the use of the HPS as a measure of bipolar spectrum 
psychopathology. 
 Consistent with Kwapil et al. (2000), the HPS predicted borderline personality 
disorder traits at the follow-up. This finding is not surprising, given the 
phenomenological overlap across borderline and bipolar psychopathology with regard to 
affective instability and impulsivity (Antoniadis et al., 2012; Coulston et al., 2012; Paris 
et al., 2007). The HPS did not predict borderline personality traits in a reduced sample 
after removing participants with DSM bipolar disorders, however, suggesting that the 
symptom overlap across borderline personality and bipolar psychopathology may be 
especially prominent at the extreme end of the bipolar spectrum. This finding 
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contradicted results from the initial assessment (Walsh et al., 2012), which found that the 
HPS was associated with borderline personality traits even after removing participants 
with DSM bipolar disorder. Thus, the extent to which borderline traits are present across 
the bipolar spectrum remains unclear. No participants met full diagnostic criteria at the 
follow-up for borderline personality disorder. Although this may be due in part to the 
young age range of the participants, this finding lends support for the HPS’ ability to 
differentiate between bipolar and borderline psychopathology, given that the HPS readily 
predicted bipolar spectrum disorders, but not borderline personality disorder. The finding 
that the HPS did not predict the borderline trait of affective instability may at first seem 
surprising, but is consistent with the conjecture that affective dysregulation is different in 
borderline and bipolar spectrum disorders (Antoniadis et al., 2012; Coulston et al., 2012; 
Paris et al., 2007). 
 Following Kwapil et al. (2000), the HPS predicted schizotypal personality 
disorder traits. Schizotypal personality disorder is included within the multidimensional 
construct of schizotypy (Kwapil & Barrantes-Vidal, 2012), and includes the positive 
symptoms of odd beliefs or magical thinking, strange perceptual experiences, and 
tangential speech or loose associations. The HPS predicted schizotypal personality 
symptoms both in the total sample and among participants without DSM bipolar 
disorders, suggesting that schizotypal traits are distributed across the bipolar spectrum 
and are not exclusive to DSM bipolar disorders. These results are also consistent with 
previous research documenting an association between positive schizotypy and mood 
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disorders (Kwapil et al., 2008), and support the notion of overlap across the affective and 
schizophrenia spectrums (Jones & Tarrant, 1999). 
Impulsivity and the HPS 
 The present study replicates previous research (Walsh et al., 2012) suggesting that 
bipolar spectrum psychopathology is associated with impulsivity. Consistent with 
hypotheses, the HPS predicted urgency, lack of premeditation, sensation seeking, as well 
as impulsive-nonconformity at the follow-up assessment. Kwapil et al. (2000) found that 
high scorers on both the HPS and impulsive-nonconformity had higher rates of bipolar 
disorders and other maladaptive outcomes, in comparison to participants with high scores 
on the HPS alone. The present research attempted to expand these findings by examining 
the moderating role of impulsivity, as measured by UPPS urgency and sensation seeking, 
and ESM ratings of risky behavior in daily life, on the relation of the HPS with bipolar 
spectrum disorders and global functioning. The results of the present research were non-
significant. This may be due in part to the fact that there is considerable shared variance 
between the HPS and the impulsivity moderators (Walsh et al., 2012). Additionally, 
neither of the UPPS moderators (urgency and sensation seeking), nor the ESM measure 
of risky behavior adequately taps the construct of impulsive-conformity. Urgency 
characterizes a tendency to act impulsively in the face of negative affect, but does not 
capture the unwillingness to conform to society’s norms or lack of empathy associated 
with impulsive-nonconformity. Similarly, sensation seeking fails to tap the construct as it 
measures a preference for exciting activities and openness to danger. Unfortunately, the 
Impulsive-Nonconformity Scale was administered at the follow-up, but not the initial 
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assessment, and therefore was inappropriate to use as a moderator of risk for bipolar 
spectrum disorders and other adverse outcomes, as the results would be confounded by 
present symptoms. Future reassessment of the sample, however, would provide an 
opportunity to attempt to replicate the findings of Kwapil et al. (2000) and examine 
impulsive-nonconformity’s effect on transition to bipolar spectrum disorders. It is also 
worth noting that the moderating effects of impulsivity were identified when participants 
were almost a decade older than the present sample on average. It may be that the 
deleterious moderating effects of impulsivity are not as readily detectable in early 
adulthood as compared to later stages of life. 
Dimensional Assessment of Bipolar Spectrum Psychopathology 
Epidemiological research (Angst et al., 2003, 2010; Hoertel et al., 2013; 
Merikangas et al., 2007; Zimmermann et al., 2009) has examined the identification of 
bipolar spectrum disorders characterized by subthreshold mood episodes, such as 
depression with subthreshold hypomania. If the bipolar spectrum is dimensional, one 
would expect to find DSM mood episodes at the extreme right end of the spectrum, and 
to find evidence of subthreshold mood episodes as one moves further to the left along the 
dimension. Following recommendations from one of these epidemiological studies (i.e., 
Angst et al., 2003), the present research included a preliminary examination of the 
validity of a continuous rating system for measuring bipolar spectrum characteristics. The 
rating system provided quantitative ratings of current and lifetime most severe episodic 
bipolar spectrum characteristics across five domains: disturbances in affect, behavior, 
cognition, sense of self, and somatic disturbances.  
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The HPS predicted episodic disturbances in affect, behavior, cognition, and sense 
of self in the total sample. However, in contrast to expectations, it did not predict these 
ratings among participants without DSM bipolar disorders. This suggests that the HPS 
predicts episodic disturbances in these domains, but only at the extreme end of the 
bipolar spectrum. Given previous epidemiological studies documenting bipolar spectrum 
disorders characterized by subthreshold mood episodes (Angst et al., 2003, 2010; Hoertel 
et al., 2013; Merikangas et al., 2007; Zimmermann et al., 2009), it is unclear why the 
HPS did not identify subclinical episodic bipolar characteristics. In contrast, the HPS 
identified bipolar spectrum disorders characterized by hyperthymic temperament, which 
was not captured by the continuous rating system. Nine of the 13 new cases of bipolar 
spectrum disorder (69%) identified by the HPS were characterized by hyperthymic 
temperament and history of clinical mood episode(s). Thus, the continuous rating scale 
used in the present study did not capture the symptoms experienced by these individuals. 
In hindsight, it may be the case that there was not enough measurement sensitivity in the 
subclinical range of symptoms.  
The results of the present research naturally raise concern regarding whether the 
continuous rating scale should have included a measure of trait-like functioning. 
Considering the epidemiological support for bipolar spectrum disorders characterized by 
subthreshold mood episodes in conjunction with the present findings, it seems reasonable 
that a rating scale that assesses clinical and subclinical episodic bipolar characteristics, as 
well as affective temperaments (e.g., hyperthymic, cyclothymic, dysthymic 
temperaments) would best capture the bipolar spectrum. This would allow for further 
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validation of Akiskal’s (2004) constructs of bipolar II ½, III, and IV, as well as bipolar 
spectrum disorders characterized by subthreshold mood episodes (e.g., major depression 
and subthreshold hypomania, hypomania and subthreshold depression). Moreover, the 
present results offer support for the exploration of the role of affective temperaments, 
especially hyperthymic temperament, within the bipolar spectrum. 
Future Study of the HPS and the Bipolar Spectrum 
The present study reflects results in progress with respect to the predictive validity 
of the HPS. Ideally, reassessing participants in approximately 7 years would allow for 
examination of the HPS’ prediction of bipolar spectrum psychopathology well beyond 
the peak age of onset of bipolar disorders. Furthermore, more frequent reassessments 
would be ideal given the cyclical and changing nature of bipolar psychopathology. Future 
longitudinal research could expand upon these findings and Kwapil et al.’s (2000) 
research to further elucidate risk and protective factors associated with the development 
of DSM bipolar disorders. There was tremendous variation in the present study with 
respect to mood symptoms and functioning associated with high scores on the HPS, 
ranging from participants with clinical bipolar disorders to participants with hyperthymic 
characteristics without a bipolar diagnosis. This is consistent with the idea that the HPS 
taps a spectrum of bipolar psychopathology; thus, not everyone with a high HPS score is 
expected to develop a DSM bipolar disorder. Regarding individuals who only exhibit 
hyperthymic characteristics, some of these participants likely displayed healthy, adaptive 
functioning, whereas others (especially those exhibiting risky behavior) likely exhibited 
impairment. Future studies therefore could examine the extent to which specific aspects 
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of hyperthymic temperament serve as risk or protective factors for the development of 
bipolar disorders. Specifically, in the present research, the HPS only uniquely predicted 
the short sleeper characteristic of hyperthymic temperament among individuals with 
DSM bipolar disorders. Future research could examine whether trait-like decreased need 
for sleep serves as a specific risk factor for DSM bipolar disorders, as suggested by 
Gruber et al. (2009). Similarly, future follow-up studies could examine whether the 
supposedly adaptive aspects of hyperthymic temperament, such as upbeat mood and high 
energy, are protective with respect to the development of clinical bipolar disorders.  
The present research was limited with respect to its assessment of adaptive 
functioning and protective factors. Consistent with previous studies of the HPS (e.g., 
Kwapil et al., 2000; Walsh et al., 2012), this research focused on the HPS’ prediction of 
impairment. However, as noted, individuals with hyperthymic temperament may exhibit 
superior functioning to their peers. Reducing participants’ functioning to a single GAF 
score based on the past month fails to account for the cyclical nature of bipolar spectrum 
disorders—and the potential for participants to exhibit different levels of functioning 
within a brief time period and within different contexts. Future research could include 
measures of current functioning, as well as best and worst psychosocial functioning (e.g., 
in the past six months).  
Future assessments could also examine the cyclical nature of bipolar spectrum 
disorders using ESM. At the present time, there are two snapshots of participants’ 
functioning: at the initial assessment and the 3-year follow-up. These assessments were 
limited to the extent that they could examine fluctuations in mood, functioning, and 
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impairment associated with bipolar spectrum disorders. Although the initial assessment 
employed ESM, the assessment took place over a brief 1-week period (Walsh et al., 
2012). Future research could utilize ESM over longer assessment periods or administer 
ESM protocols at specific intervals over longer periods of time. For example, Trull et al. 
(2008) employed ESM measures for 1 month to examine affective instability in patients 
with borderline personality and depressive disorders. Prolonged assessment of 
participants in daily life would better capture the dynamic nature of mood and 
functioning associated with bipolar spectrum disorders. Additionally, ESM may also 
further elucidate risk and protective factors associated with daily life functioning, such as 
social contact. 
Practical Implications and Challenges 
 The present findings offer support for the construct of a bipolar spectrum that 
extends beyond the existing diagnostic boundaries. Identifying individuals who fall on 
the bipolar spectrum should help us better understand risk and protective factors, as well 
as opportunities for early intervention. There are challenges, however, associated with the 
initial step of identifying individuals with bipolar spectrum psychopathology. 
Specifically, there are contrasting opinions with regard to how to define the bipolar 
spectrum (Kuiper, Curran, & Malhi, 2012). The present study included Akiskal’s (2004) 
bipolar spectrum disorders; however, epidemiological studies of subthreshold bipolarity 
have generally excluded assessment of affective temperaments. Rather, epidemiological 
research has attempted to validate a subthreshold bipolar disorder using inconsistent 
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definitions. Therefore, we are left with evidence for a broader bipolar spectrum, but its 
boundaries remain quite murky.  
Following Nusslock and Frank’s (2011) review, the benefits of identifying 
individuals with bipolar spectrum disorders are also met with challenges. For example, 
even if we can successfully identify individuals with subthreshold bipolarity, when is it 
reasonable to intervene? And by what means? Nusslock and Frank (2011) argue in favor 
of modifying existing psychosocial interventions for individuals with subsyndromal 
hypomania on the grounds that subsyndromal hypomanic presentations are associated 
with impairment. Specifically, they support offering individuals and family members 
education regarding the early warning signs of hypomania and mania and on life events 
that may trigger mood episodes, as well as strategies for maintaining consistent social and 
circadian rhythms. The authors argue against the use of mood stabilizers or antipsychotic 
medications for individuals with subthreshold bipolarity, specifically major depression 
and subthreshold hypomania, on the basis that there is no clinical or scientific evidence to 
support it. Furthermore, antidepressant medications should be used judiciously given that 
some classes of these medications can actually precipitate hypomanic and manic 
episodes. Analogous debates are occurring in regard to precursor or prodromal signs of 
schizophrenia. For example, DSM-5 considered the inclusion of an at-risk mental state 
diagnosis, but subsequently opted to include it in the criteria for further study due in large 
part to concerns that clinicians would not be able to discriminate between a risk state and 
disorder. Bipolar disorder is even more complex because many of the risk features can be 
associated with adaptive functioning. 
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Considering the nature of the bipolar spectrum disorders in the present study, 
even the rather benign treatment of psychoeducation carries risks. Presuming that a 
subset of individuals with bipolar spectrum disorders will never develop clinical bipolar 
disorders, there is potential harm in informing individuals of their at-risk status. 
Providing such information could result in unnecessary stress and anxiety, promote 
stigma, and result in discrimination. Furthermore, if impairment is used as a basis for 
offering interventions, this can become quite complicated given that bipolar spectrum 
psychopathology may be characterized by adaptive functioning. These concerns are even 
more pronounced when considering identification and intervention for individuals who 
do not exhibit bipolar spectrum disorders, but simply exhibit affective temperaments or 
subsyndromal symptoms. Although Nusslock and Frank’s (2011) recommendations seem 
well-intended, and may be appropriate for individuals with subsyndromal hypomania and 
impairment, until we have a better understanding of the benefits of psychosocial 
interventions across the bipolar spectrum, they should be used with caution. 
Although there is growing evidence for a broader bipolar spectrum, there 
continues to be controversy regarding how to define it. The lack of consensus on a 
definition for the bipolar spectrum makes the discussion of early interventions 
challenging and only speculative. The present research adds to the evidence-base for a 
bipolar spectrum that extends beyond existing diagnostic nomenclature, and offers 
support for the validity of the HPS as a tool for identifying individuals at risk at the group 
level. Ultimately, accurate identification of individuals who fall on the bipolar spectrum 
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will aid understanding of risk and protective factors, as well as the underlying etiology of 
bipolar disorders. 
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APPENDIX A 
 
TABLES & FIGURES 
 
 
Table 1. Comparison of Ratings and Demographic Information from the Initial    
  Assessment for the Total, Follow-Up, and Non-Followed Samples  
 
 
Initial Assessment Criterion 
 
Total Sample 
(n = 145) 
 
Follow-Up 
(n = 100) 
 
Non-Followed 
(n = 45) 
    
HPS score (mean, SD) 20.1 (10.1) 20.5 (10.6) 19.1 (9.0) 
Bipolar spectrum disorder (no. and %) 
 
22 (15.2%) 15 (15.0%) 7 (15.6%) 
GAF – Global functioning (mean, SD) 
 
76.1 (12.8) 76.1 (12.6) 76.2 (13.1) 
% female participants 69.0%  66.0%  75.6% 
Age (mean, SD) 19.5 (2.3) 19.5 (2.6) 19.4 (1.3) 
% Caucasian 64.8% 64.0% 66.7% 
% African American 15.9% 18.0% 11.1% 
% Hispanic 4.1% 4.0% 4.4% 
% Asian 4.1% 5.0% 2.2% 
% Other 4.1% 4.0% 4.4% 
% Unspecified 6.9% 5.0% 11.1% 
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Table 2. Summary of Follow-Up Assessment Diagnostic Outcomes by Diagnostic Status at the Initial Assessment 
 
  Diagnostic Status at the 
Initial Assessment 
 
Diagnostic Status of Reassessed 
Participants at the Follow-Up Assessment 
 
Initial Assessment 
Diagnostic Status 
All 
Participants 
(n = 145) 
Participants 
Reassessed 
(n =100) 
 
DSM 
Bipolar Disorder 
 
Non-DSM 
Bipolar Disorder 
 
No Bipolar 
Disorder 
      
No bipolar disorder 123 85 3 10 72 
DSM bipolar disorder 15 9 6 2 1 
Non-DSM bipolar disorder 7 6 1 4 1 
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Table 3. Binary Logistic Regressions of the HPS Predicting Mood Psychopathology,    
  Substance Use Disorders, Treatment History, and Family History  
 
  Prediction by the HPS 
    
 
Criterion 
           % of 
sample 
Odds 
Ratio 
95% Confidence  
Interval 
    
DSM bipolar disorder 10% 1.16** 1.05-1.29 
    
Bipolar spectrum disorder 26% 1.17*** 1.09-1.26 
    
Hypomania or hyperthymic  
temperament 
34% 1.27*** 1.16-1.39 
    
Major depressive episode  44% 1.02 0.98-1.05 
    
Major depressive disorder 22% 0.93** 0.89-0.98 
    
Alcohol abuse or dependence 12% 1.08* 1.01-1.15 
    
Drug abuse or dependence 18% 1.07* 1.01-1.13 
    
Mental health treatment  30% 1.02 0.98-1.06 
    
Family history of mood disorder 55% 0.98 0.95-1.02 
 
 
* p < .05 ** p < .01 *** p < .001 
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Table 4. Zero-Order Correlations of the HPS Predicting Continuous Measures of Psychopathology  
  
Follow-Up Sample 
(n = 100) 
 DSM Bipolar 
Disorders Removed  
(n = 90) 
       
 
Criterion 
 
Mean 
 
SD 
Coefficient 
α
a 
Pearson Correlation  
(2-tailed) with the HPS
 
 Pearson Correlation  
(2-tailed) with the HPS 
       
Hyperthymic temperament  
total score 
5.95 4.01 - .68***  .69*** 
       
Psychosocial Functioning        
     GAF – Global functioning 73.94 11.58 - -.32**  -.25* 
     Role functioning 8.41 1.04 - -.03  -.11 
     Social functioning 8.03 1.01 - -.16  -.15 
       
IPDE       
     Borderline dimensional score 1.56  2.21 - .32**  .21 
     Schizotypal dimensional score 1.05 1.51 - .34***  .28** 
       
Impulsive-Nonconformity  10.71 7.18 0.87 .59***  .54*** 
       
UPPS Impulsivity       
     Urgency 2.00 0.55 0.88 .42***  .34** 
     Lack of premeditation 1.87 0.47 0.85 .35***  .33** 
     Lack of perseverance 1.73 0.44 0.78 .13  .13 
     Sensation seeking 2.83 0.61 0.85 .38***  .40*** 
       
Grandiosity Questions       
     Famous 2.01 1.49 - .52***  .52*** 
     Odd/Different 2.54 1.22 - .49***  .45*** 
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Table 4 (continued) 
 
 
 
 
 
Follow-Up Sample 
(n = 100) 
  
 
DSM Bipolar 
Disorders Removed  
(n  = 90) 
       
 
Criterion 
 
Mean 
 
SD 
Coefficient 
α
a 
Pearson Correlation  
(2-tailed) with the HPS
 
 Pearson Correlation  
(2-tailed) with the HPS 
       
     Magazine 1.82 1.51 - .42***  .43*** 
     Attention 0.40 0.49 - .44***  .38*** 
     Creative 2.68 1.25 - .37***  .35** 
     Ambition 2.98 0.89 - .29**  .31** 
     Leadership 0.67 0.47 - .20*  .21* 
       
Alcohol Use and Impairment       
Current alcohol use 3.28 3.80 - .23*  .24* 
Heaviest alcohol use 7.17 6.54 - .27**  .28** 
Current alcohol impairment 0.83 0.64 - .30**  .32** 
Heaviest alcohol impairment 1.29 1.01 - .37***  .37*** 
       
Drug Use and Impairment       
Current drug use .68 1.85 - .22*  .26* 
Heaviest drug use 3.04 5.69 - .25*  .28** 
Current drug impairment 0.29 0.73 - .25*  .30** 
Heaviest drug impairment 0.86 1.17 - .22*   .25* 
  
 
     
* p < .05 ** p < .01 *** p < .001 
 
a
 coefficient α reported for questionnaire measures 
Medium effect sizes in bold, large effect sizes in bold and italics
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Table 5. Zero-Order Correlations of the HPS Predicting Hyperthymic Temperament Characteristics across    
  Participants with and without Bipolar Spectrum Disorders 
 
 
 
 
Criterion 
 
 
Pearson Correlation  
(2-tailed) with the HPS in the 
follow-up sample (n = 100) 
 
Pearson Correlation  
 (2-tailed) with the HPS 
after removing DSM 
bipolar disorders (n = 90)
 
 
Pearson Correlation  
(2-tailed) with the 
HPS after removing 
bipolar spectrum 
disorders (n = 74)
 
 
    
Hyperthymic temperament total score .68*** .69*** .60*** 
     Upbeat/exuberant mood .48*** .52*** .45*** 
     Overinvolved and meddlesome .56*** .51*** .44*** 
     Broad interests .45*** .45*** .40*** 
     Overconfident and boastful .35*** .41*** .39** 
     Articulate and jocular .50*** .49*** .34** 
     High energy level/full of plans .41*** .41*** .32** 
     Uninhibited and risk-taking .36*** .36** .30** 
     Overoptimistic and carefree .26** .34** .26* 
     Short sleeper (<6 hrs) .26* .29** .14 
   
 
 
* p < .05 ** p < .01 *** p < .001 
 
Medium effect sizes in bold, large effect sizes in bold and italics 
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Table 6. Zero-Order Correlations of the HPS Predicting Lifetime Measures of Bipolar    
  Spectrum Characteristics 
 
 
 
 
 
 
 
Criterion 
 
 
 
 
 
 
Mean 
 
 
 
 
 
 
SD 
 
Pearson  
Correlation  
(2-tailed) with  
the HPS in the 
follow-up sample  
(n = 100) 
Pearson 
Correlation  
(2-tailed) with    
the HPS after 
removing DSM 
bipolar disorders 
(n = 90)
 
 
     
Affective disturbance .27 .78 .37*** .07 
     
Behavioral disturbance .29 .82 .29** .00 
     
Cognitive disturbance .29 .86 .35*** .06 
     
Disturbances in sense 
of self 
.21 .66  .31** .07 
     
Somatic disturbance  .10 .52 .19 -.04 
     
     
* p < .05 ** p < .01 *** p < .001 
 
Medium effect sizes in bold 
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Table 7. Binary Logistic Regressions Examining the Moderating Effect of Impulsivity on the Relation 
  of the HPS with Bipolar Spectrum Disorders  
 
 Step 1   Step 2 
        
 Urgency  HPS    Urgency x HPS interaction 
         
Criterion Odds ratio 95% CI Odds ratio 95% CI   Odds ratio 95% CI 
         
Bipolar spectrum 
disorders 
2.18 0.72-6.63 1.17*** 1.08-1.26   0.97 0.83-1.13 
         
 
 
 
Sensation seeking 
 
HPS 
    
Sensation seeking x HPS interaction  
         
 Odds ratio 95% CI Odds ratio 95% CI   Odds ratio 95% CI 
         
Bipolar spectrum 
disorders 
0.70 0.29-1.73 1.18*** 1.10-1.28   1.06 0.97-1.16 
         
         
 Risky behavior HPS    Risky behavior x HPS interaction 
         
 Odds ratio 95% CI Odds ratio 95% CI   Odds ratio 95% CI 
         
Bipolar spectrum 
disorders 
1.53 0.65-3.60 1.16*** 1.08-1.25   0.98 0.85-1.13 
 
 
* p < .05 ** p < .01 *** p < .001 
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Table 8. Linear Regressions Examining the Moderating Effect of Impulsivity on the Relation of the HPS with Global             
  Functioning  
 
 Step 1  Step 2 
 
 
 
Urgency                      HPS 
   
Urgency x  HPS interaction 
       
Criterion B B   ΔR
2
     Β    ΔR
2
 
         
GAF – Global functioning -.161 -.255  .125**   .106 .011 
          
         
 Sensation seeking HPS     Sensation seeking x HPS interaction 
         
 B B  ΔR
2
   B ΔR
2
 
         
GAF – Global functioning -.006 -.320  .104**   -.185 .034 
         
         
 Risky behavior HPS     Risky behavior x HPS interaction 
         
 B B  . ΔR
2
   B ΔR
2
 
         
GAF – Global functioning .031 -.346  .112**   .035 .001 
         
 
 
* p < .05 ** p < .01 *** p < .001 
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Figure 1. Percentage of Participants with Bipolar Spectrum Disorders at the Follow-Up Assessment by HPS Score 
                                                            
 
 
 
Figure 2. Percentage of Participants with Hypomania or Hyperthymic Temperament at the Follow-Up Assessment by    
  HPS Score 
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Figure 3. Association of the HPS at the Initial Assessment with Global Functioning at the Follow-Up Assessment 
 
 
